| Jun 5 |
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
|
| Jun 5 |
Insider Sale: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
|
| Jun 4 |
Insider Sale: VP, Chief Accounting Officer Robert Wong Sells Shares of Cytokinetics Inc (CYTK)
|
| May 29 |
Cytokinetics to Participate in June Investor Conferences
|
| May 28 |
Cytokinetics Announces Closing of Public Offering of Common Stock
|
| May 27 |
Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now?
|
| May 24 |
Cytokinetics Decides To Go It Alone
|
| May 24 |
Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday
|
| May 23 |
Cytokinetics secures up to $575M in royalty deal, frustrating investors
|
| May 23 |
Cytokinetics drops after pricing public offering, debt deal; brokerages cut PT
|
